Literature DB >> 941889

Bacteroides fragilis ventriculitis and meningitis. Report of two cases.

W E Feldman.   

Abstract

Two patients with Bacteroides fragilis meningitis and ventriculitis were treated. In one infant infection developed at 2 1/2 months of age as a result of an infected ventriculoatrial shunt inserted to treat hydrocephalus. In the second patient ventriculitis and meningitis developed at 20 days of age, while he was convalescing from surgery for gastric perforation that had occurred at 5 days of age. Both patients were treated with ampicillin, chloramphenicol, and clindamycin, which sterilized the blood and lumbar cerebrospinal fluid but not the ventricular cerebrospinal fluid. The first patient received no further antibiotic therapy and died at 5 months of age. Metronidazole therapy sterilized the ventricular fluid of the second patient, who survived the infection. Ventriculitis should be suspected in patients with B fragilis meningitis. A brain scan should be done to detect signs of ventriculitis or brain abscess. Metronidazole may be the drug of choice in patients with B fragilis ventriculitis or meningitis who do not respond to chloramphenicol.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941889     DOI: 10.1001/archpedi.1976.02120090090017

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

Review 1.  Anaerobic meningitis in children.

Authors:  A Tärnvik
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

Review 2.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  Meningitis caused by Bacteroides fragilis.

Authors:  M Montejo Baranda; P Gonzalez de Zarate Apiñamiz; J Barron Fernandez; C Aguirre Errasti
Journal:  Can Med Assoc J       Date:  1984-08-01       Impact factor: 8.262

4.  Anaerobic bacterial infections in children-Part I.

Authors:  H Thadepalli
Journal:  Indian J Pediatr       Date:  1981 Nov-Dec       Impact factor: 1.967

5.  Primary meningitis caused by Bacteroides fragilis and Fusobacterium necrophorum.

Authors:  A K Islam; J M Shneerson
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

6.  Cerebrospinal fluid concentrations of metronidazole, tinidazole and ornidazole in rabbits.

Authors:  A M Jokipii; L Jokipii
Journal:  Infection       Date:  1980       Impact factor: 3.553

Review 7.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

8.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  M M París; S Shelton; M Trujillo; S M Hickey; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Metronidazole and hydroxymetronidazole central nervous system distribution: 1. microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury.

Authors:  Denis Frasca; Claire Dahyot-Fizelier; Christophe Adier; Olivier Mimoz; Bertrand Debaene; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.